Gerard Comas-Quiles

Rémi Grzeczkowicz, Eric Soriano, Ali Janati et al.

In this work, we present a lightweight and privacy-preserving Multimodal Emotion Recognition (MER) framework designed for deployment on edge devices. To demonstrate framework's versatility, our implementation uses three modalities - speech, text and facial imagery. However, the system is fully modular, and can be extended to support other modalities or tasks. Each modality is processed through a dedicated backbone optimized for inference efficiency: Emotion2Vec for speech, a ResNet-based model for facial expressions, and DistilRoBERTa for text. To reconcile uncertainty across modalities, we introduce a model- and task-agnostic fusion mechanism grounded in Dempster-Shafer theory and Dirichlet evidence. Operating directly on model logits, this approach captures predictive uncertainty without requiring additional training or joint distribution estimation, making it broadly applicable beyond emotion recognition. Validation on five benchmark datasets (eNTERFACE05, MEAD, MELD, RAVDESS and CREMA-D) show that our method achieves competitive accuracy while remaining computationally efficient and robust to ambiguous or missing inputs. Overall, the proposed framework emphasizes modularity, scalability, and real-world feasibility, paving the way toward uncertainty-aware multimodal systems for healthcare, human-computer interaction, and other emotion-informed applications.

Gerard Comas-Quiles, Carles Garcia-Cabrera, Julia Dietlmeier et al.

Unsupervised anomaly detection (UAD) presents a complementary alternative to supervised learning for brain tumor segmentation in magnetic resonance imaging (MRI), particularly when annotated datasets are limited, costly, or inconsistent. In this work, we propose a novel Multimodal Vision Transformer Autoencoder (MViT-AE) trained exclusively on healthy brain MRIs to detect and localize tumors via reconstruction-based error maps. This unsupervised paradigm enables segmentation without reliance on manual labels, addressing a key scalability bottleneck in neuroimaging workflows. Our method is evaluated in the BraTS-GoAT 2025 Lighthouse dataset, which includes various types of tumors such as gliomas, meningiomas, and pediatric brain tumors. To enhance performance, we introduce a multimodal early-late fusion strategy that leverages complementary information across multiple MRI sequences, and a post-processing pipeline that integrates the Segment Anything Model (SAM) to refine predicted tumor contours. Despite the known challenges of UAD, particularly in detecting small or non-enhancing lesions, our method achieves clinically meaningful tumor localization, with lesion-wise Dice Similarity Coefficient of 0.437 (Whole Tumor), 0.316 (Tumor Core), and 0.350 (Enhancing Tumor) on the test set, and an anomaly Detection Rate of 89.4% on the validation set. These findings highlight the potential of transformer-based unsupervised models to serve as scalable, label-efficient tools for neuro-oncological imaging.